Rise of the Robots: Scaling Up Cell Therapies in Small Spaces
October 29, 2025
Manual processes in cell therapy manufacturing are unsustainable. Bring in the robots.
3 min read
Interviews
FOYA: Celebrating Innovation in Pharma Facilities
By Stephanie Vine
October 7, 2025
We interview Scott Billman, one of the judges of the ISPE Facility of the Year Awards, to learn more about the 2025 winners and the trends impacting facilities.
10 min read
The Golden Age of Drug Discovery
By Stephanie Vine
October 6, 2025
Sitting down with Insmed’s Tom Heightman, we discuss new technologies for drug discovery and the promise of human genome sequencing data.
7 min read
Going Green Without Sacrificing Lab Equipment Performance
By Rob Coker
September 16, 2025
Single-use plastics remain essential in labs, but their environmental impact is hard to ignore...
4 min read
Chemistry and Crazy Ideas: Getting to Know Ali Tavassoli
August 27, 2025
Learning more about the people behind this year’s Power List: Ali Tavassoli, Chief Scientific Officer of Curve Therapeutics
10 min read
From Pilot Dreams to Drug Development: Interviewing Subas Sakya
By Stephanie Vine
August 26, 2025
We sit down with the Chief Scientific Officer of BioDuro to find out what he wanted to be as a child and how he came to love drug development.
10 min read
Implementing Green Chemistry into API Manufacturing
August 22, 2025
Early API development can drive environmental gains without sacrificing speed or yield.
8 min read
Formulating for Safety: How to Minimize Nitrosamine Risk
August 15, 2025
What should the industry do to tackle nitrosamines? It comes down to excipient selection, process control, and predictive tools.
7 min read
What's the Latest in the US with Pharma and Trump?
By Rob Coker
August 12, 2025
Industry expert Audrey Greenberg gives the latest update on US pharma, Trump policies, and how pharma supply chains are affected
2 min read
From Manual to Metadata: How Novo Nordisk is Rewiring Clinical Trials
July 30, 2025
Tech companies and drug developers are aiming for faster, more efficient, completely compliant clinical trials through the use of AI – and there’s no such thing as too much data.
4 min read
